After asthma: redefining airways diseases
Ian Pavord(University of Oxford), Richard Beasley(Medical Research Institute of New Zealand), Àlvar Agustí(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Gary P. Anderson(The University of Melbourne), Elisabeth H. Bel(Amsterdam UMC Location University of Amsterdam), Guy Brusselle(Ghent University Hospital), Paul Cullinan(Imperial College London), Adnan Čustović(Imperial College London), Francine M. Ducharme(Université de Montréal), John V. Fahy(University of California, San Francisco), Urs Frey(University of Basel), Peter G. Gibson(John Hunter Hospital), Liam G. Heaney(Queen's University Belfast), Patrick G. Holt(The Kids Research Institute Australia), Marc Humbert(Université Paris-Sud), Clare M. Lloyd(Imperial College London), Guy B. Marks(UNSW Sydney), Fernando D. Martínez(University of Arizona), Peter D. Sly(Children's Medical Research Institute), Erika von Mutius(Ludwig-Maximilians-Universität München), Sally E. Wenzel(University of Pittsburgh), Heather J. Zar(University of Cape Town), Andy Bush(Imperial College London)
Cited by 1,035Open Access
Abstract
momentum to the recent encouraging progress in new drug discovery and, as did the first asthma guidelines published 27 years ago, 14-17 lead to a decade or more of improved outcomes. We conclude the Commission with seven key recom mendations and summarise our views on how these could be developed to benefit patients with asthma (panel 1).
Related Papers
No related papers found
Powered by citation graph analysis